Breast Cancer
A Phase 2 Multicenter Study Evaluating the Efficacy and Safety of IPI-504 in Combination with Trastuzumab in Patients with Pretreated, Locally Advanced or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) - Positive Breast Cancer
Trial ID: 08180
Contact: Carolyn Cox
Phone: (281)863-6641
Learn More about this trial.
go back | new search